Company / SG&A per Share
Mind Medicine (MindMed) Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.54
FY2025
5-year range
$0.54 / $2.16
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#158 of 210
Health Care
What the data says
Mind Medicine (MindMed) Inc.'s sg&a per share of $0.54 is lower than 75% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 7 years, ranging from $0.03 in FY2019 to $2.16 in FY2021.
Based on SEC 10-K filings.
0.54 in FY2025 with a 5-year CAGR of +58.7%.
Improved from $1.07 to $0.54 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -17.7%
- 5-Year CAGR
- +58.7%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 210This company $0.54 Sector average $40.75
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 0.6% year-over-year.
- Ranks #158 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.54 | -0.6% |
| FY2024 | $0.55 | -48.6% |
| FY2023 | $1.07 | +9.1% |
| FY2022 | $0.98 | -54.7% |
| FY2021 | $2.16 | +3888.9% |
| FY2020 | $0.05 | +74.9% |
| FY2019 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026